Quantum-AI Drug Discovery

Accelerated Therapeutics with Quantum Computing & Artificial Intelligence

Current Projects

NDM-1 Inhibitor Project

Our flagship project targets New Delhi Metallo-β-lactamase (NDM-1), a critical enzyme in multi-drug resistant Gram-negative bacteria. Using our Quantum-AI platform, we've identified promising inhibitor candidates that could restore the efficacy of existing antibiotics against these deadly superbugs.

Latest Achievements

  • Identified ibuprofen-like scaffold as promising NDM-1 inhibitor
  • Created optimized focused library of potential inhibitors
  • Implemented zinc-binding potential assessment
  • Prepared molecular docking environment

Project Timeline

  • Platform Enhancement - Complete (May 2025)
  • Computational Analysis - Complete (May 2025)
  • Molecular Docking - In Progress (May-June 2025)
  • MD Simulations - Planned (June 2025)
  • Synthesis & Testing - Planned (June-July 2025)

Revolutionizing Pharmaceutical Development

Our Quantum-AI Drug Discovery platform combines cutting-edge quantum computing algorithms with advanced AI to dramatically accelerate the discovery and development of novel therapeutics. We're reducing the time from concept to clinical trials while increasing success rates and reducing costs.

Quantum Molecular Simulation

Utilize quantum computers to simulate molecular properties and interactions with our VQE algorithm and AWS Braket integration for cloud quantum resources.

AI-Driven Design

Our deep learning models generate novel molecular structures optimized for specific therapeutic targets, with multiple quantum ansatz options.

Accelerated Discovery

Reduce drug discovery timelines from years to months by combining quantum calculations with classical ML workflows and interactive visualization.

Custom Molecule Generation

Tailor-made molecule generation services with comprehensive drug-likeness scoring and advanced property calculation for optimal candidates.

Antiviral Research Focus

Dedicated antiviral research platform capable of rapid response to emerging viral threats through accelerated therapeutic development.

Quantum-AI Drug Discovery Process

Our integrated quantum computing and AI platform accelerates every stage of the drug discovery pipeline

Who Benefits from Our Quantum-AI Drug Discovery Services?

Our cutting-edge platform is designed to serve the specific needs of:

Pharmaceutical Companies Biosecurity Agencies SBIR Partners DARPA/BARDA Research Institutions Biotech Startups Clinical Research Organizations

Ready to Accelerate Your Drug Discovery?

Let's discuss how our Quantum-AI platform can transform your pharmaceutical research and development.

Contact Our Team